nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadobenate Dimeglumine—ALB—lung cancer	0.437	1	CbGaD
Gadobenate Dimeglumine—ALB—Gefitinib—lung cancer	0.134	0.415	CbGbCtD
Gadobenate Dimeglumine—ALB—Erlotinib—lung cancer	0.079	0.246	CbGbCtD
Gadobenate Dimeglumine—ALB—Irinotecan—lung cancer	0.0713	0.222	CbGbCtD
Gadobenate Dimeglumine—ALB—Methotrexate—lung cancer	0.0378	0.117	CbGbCtD
Gadobenate Dimeglumine—Feeling abnormal—Cisplatin—lung cancer	8.03e-05	0.000333	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Etoposide—lung cancer	8.02e-05	0.000333	CcSEcCtD
Gadobenate Dimeglumine—Haematuria—Methotrexate—lung cancer	8e-05	0.000332	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Docetaxel—lung cancer	7.99e-05	0.000332	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Paclitaxel—lung cancer	7.98e-05	0.000331	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Etoposide—lung cancer	7.96e-05	0.00033	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Etoposide—lung cancer	7.94e-05	0.000329	CcSEcCtD
Gadobenate Dimeglumine—Cough—Docetaxel—lung cancer	7.94e-05	0.000329	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Irinotecan—lung cancer	7.91e-05	0.000328	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Paclitaxel—lung cancer	7.86e-05	0.000326	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Docetaxel—lung cancer	7.85e-05	0.000326	CcSEcCtD
Gadobenate Dimeglumine—Bronchitis—Doxorubicin—lung cancer	7.83e-05	0.000325	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Paclitaxel—lung cancer	7.81e-05	0.000324	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Paclitaxel—lung cancer	7.78e-05	0.000323	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Docetaxel—lung cancer	7.74e-05	0.000321	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Docetaxel—lung cancer	7.74e-05	0.000321	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Docetaxel—lung cancer	7.74e-05	0.000321	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Vinorelbine—lung cancer	7.73e-05	0.000321	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Etoposide—lung cancer	7.71e-05	0.00032	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Paclitaxel—lung cancer	7.71e-05	0.00032	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Cisplatin—lung cancer	7.71e-05	0.00032	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Irinotecan—lung cancer	7.7e-05	0.00032	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Etoposide—lung cancer	7.7e-05	0.000319	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	7.69e-05	0.000319	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Etoposide—lung cancer	7.64e-05	0.000317	CcSEcCtD
Gadobenate Dimeglumine—Pain—Etoposide—lung cancer	7.64e-05	0.000317	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Docetaxel—lung cancer	7.57e-05	0.000314	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Paclitaxel—lung cancer	7.56e-05	0.000314	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Paclitaxel—lung cancer	7.55e-05	0.000313	CcSEcCtD
Gadobenate Dimeglumine—Pollakiuria—Doxorubicin—lung cancer	7.52e-05	0.000312	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Gemcitabine—lung cancer	7.5e-05	0.000311	CcSEcCtD
Gadobenate Dimeglumine—Pain—Paclitaxel—lung cancer	7.49e-05	0.000311	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Paclitaxel—lung cancer	7.49e-05	0.000311	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Docetaxel—lung cancer	7.48e-05	0.000311	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract disorder—Methotrexate—lung cancer	7.44e-05	0.000309	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Docetaxel—lung cancer	7.42e-05	0.000308	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Gemcitabine—lung cancer	7.4e-05	0.000307	CcSEcCtD
Gadobenate Dimeglumine—Urethral disorder—Methotrexate—lung cancer	7.38e-05	0.000306	CcSEcCtD
Gadobenate Dimeglumine—Infection—Docetaxel—lung cancer	7.37e-05	0.000306	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Etoposide—lung cancer	7.36e-05	0.000305	CcSEcCtD
Gadobenate Dimeglumine—Hyperglycaemia—Doxorubicin—lung cancer	7.35e-05	0.000305	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Irinotecan—lung cancer	7.35e-05	0.000305	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Etoposide—lung cancer	7.3e-05	0.000303	CcSEcCtD
Gadobenate Dimeglumine—Shock—Docetaxel—lung cancer	7.3e-05	0.000303	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Docetaxel—lung cancer	7.28e-05	0.000302	CcSEcCtD
Gadobenate Dimeglumine—Infestation NOS—Doxorubicin—lung cancer	7.26e-05	0.000301	CcSEcCtD
Gadobenate Dimeglumine—Infestation—Doxorubicin—lung cancer	7.26e-05	0.000301	CcSEcCtD
Gadobenate Dimeglumine—Visual impairment—Methotrexate—lung cancer	7.26e-05	0.000301	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Docetaxel—lung cancer	7.24e-05	0.000301	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Paclitaxel—lung cancer	7.22e-05	0.000299	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Docetaxel—lung cancer	7.21e-05	0.000299	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Cisplatin—lung cancer	7.18e-05	0.000298	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Paclitaxel—lung cancer	7.16e-05	0.000297	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Gemcitabine—lung cancer	7.16e-05	0.000297	CcSEcCtD
Gadobenate Dimeglumine—Renal failure—Doxorubicin—lung cancer	7.14e-05	0.000296	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Irinotecan—lung cancer	7.1e-05	0.000295	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Etoposide—lung cancer	7.09e-05	0.000294	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Etoposide—lung cancer	7.06e-05	0.000293	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Etoposide—lung cancer	7.06e-05	0.000293	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract infection—Doxorubicin—lung cancer	7.06e-05	0.000293	CcSEcCtD
Gadobenate Dimeglumine—Conjunctivitis—Doxorubicin—lung cancer	7.06e-05	0.000293	CcSEcCtD
Gadobenate Dimeglumine—Eye disorder—Methotrexate—lung cancer	7.04e-05	0.000292	CcSEcCtD
Gadobenate Dimeglumine—Tinnitus—Methotrexate—lung cancer	7.02e-05	0.000291	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Cisplatin—lung cancer	6.99e-05	0.00029	CcSEcCtD
Gadobenate Dimeglumine—Cardiac disorder—Methotrexate—lung cancer	6.99e-05	0.00029	CcSEcCtD
Gadobenate Dimeglumine—Sweating—Doxorubicin—lung cancer	6.96e-05	0.000289	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Paclitaxel—lung cancer	6.96e-05	0.000289	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Docetaxel—lung cancer	6.94e-05	0.000288	CcSEcCtD
Gadobenate Dimeglumine—Haematuria—Doxorubicin—lung cancer	6.92e-05	0.000287	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Paclitaxel—lung cancer	6.92e-05	0.000287	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Paclitaxel—lung cancer	6.92e-05	0.000287	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Methotrexate—lung cancer	6.83e-05	0.000283	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Irinotecan—lung cancer	6.83e-05	0.000283	CcSEcCtD
Gadobenate Dimeglumine—Immune system disorder—Methotrexate—lung cancer	6.8e-05	0.000282	CcSEcCtD
Gadobenate Dimeglumine—Mediastinal disorder—Methotrexate—lung cancer	6.79e-05	0.000282	CcSEcCtD
Gadobenate Dimeglumine—Rash—Irinotecan—lung cancer	6.77e-05	0.000281	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Irinotecan—lung cancer	6.76e-05	0.000281	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Docetaxel—lung cancer	6.76e-05	0.000281	CcSEcCtD
Gadobenate Dimeglumine—Chills—Methotrexate—lung cancer	6.76e-05	0.00028	CcSEcCtD
Gadobenate Dimeglumine—Headache—Irinotecan—lung cancer	6.73e-05	0.000279	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Cisplatin—lung cancer	6.67e-05	0.000277	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Docetaxel—lung cancer	6.66e-05	0.000277	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Gemcitabine—lung cancer	6.65e-05	0.000276	CcSEcCtD
Gadobenate Dimeglumine—Bradycardia—Doxorubicin—lung cancer	6.64e-05	0.000275	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Docetaxel—lung cancer	6.62e-05	0.000275	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Docetaxel—lung cancer	6.6e-05	0.000274	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Methotrexate—lung cancer	6.6e-05	0.000274	CcSEcCtD
Gadobenate Dimeglumine—Rash—Gemcitabine—lung cancer	6.59e-05	0.000274	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Gemcitabine—lung cancer	6.59e-05	0.000273	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Etoposide—lung cancer	6.58e-05	0.000273	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Methotrexate—lung cancer	6.55e-05	0.000272	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Methotrexate—lung cancer	6.55e-05	0.000272	CcSEcCtD
Gadobenate Dimeglumine—Headache—Gemcitabine—lung cancer	6.55e-05	0.000272	CcSEcCtD
Gadobenate Dimeglumine—Rhinitis—Doxorubicin—lung cancer	6.54e-05	0.000271	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Docetaxel—lung cancer	6.53e-05	0.000271	CcSEcCtD
Gadobenate Dimeglumine—Hypoaesthesia—Doxorubicin—lung cancer	6.49e-05	0.000269	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Paclitaxel—lung cancer	6.45e-05	0.000268	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract disorder—Doxorubicin—lung cancer	6.44e-05	0.000267	CcSEcCtD
Gadobenate Dimeglumine—Oedema peripheral—Doxorubicin—lung cancer	6.42e-05	0.000266	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Methotrexate—lung cancer	6.42e-05	0.000266	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Docetaxel—lung cancer	6.41e-05	0.000266	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Etoposide—lung cancer	6.41e-05	0.000266	CcSEcCtD
Gadobenate Dimeglumine—Connective tissue disorder—Doxorubicin—lung cancer	6.41e-05	0.000266	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Docetaxel—lung cancer	6.4e-05	0.000265	CcSEcCtD
Gadobenate Dimeglumine—Urethral disorder—Doxorubicin—lung cancer	6.39e-05	0.000265	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Irinotecan—lung cancer	6.38e-05	0.000265	CcSEcCtD
Gadobenate Dimeglumine—Pain—Docetaxel—lung cancer	6.35e-05	0.000263	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Docetaxel—lung cancer	6.35e-05	0.000263	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Methotrexate—lung cancer	6.34e-05	0.000263	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Etoposide—lung cancer	6.32e-05	0.000262	CcSEcCtD
Gadobenate Dimeglumine—Visual impairment—Doxorubicin—lung cancer	6.28e-05	0.000261	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Paclitaxel—lung cancer	6.28e-05	0.000261	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Gemcitabine—lung cancer	6.21e-05	0.000258	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Cisplatin—lung cancer	6.2e-05	0.000257	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Paclitaxel—lung cancer	6.19e-05	0.000257	CcSEcCtD
Gadobenate Dimeglumine—Rash—Cisplatin—lung cancer	6.15e-05	0.000255	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Cisplatin—lung cancer	6.14e-05	0.000255	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Docetaxel—lung cancer	6.12e-05	0.000254	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Etoposide—lung cancer	6.11e-05	0.000254	CcSEcCtD
Gadobenate Dimeglumine—Eye disorder—Doxorubicin—lung cancer	6.09e-05	0.000253	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Methotrexate—lung cancer	6.08e-05	0.000252	CcSEcCtD
Gadobenate Dimeglumine—Tinnitus—Doxorubicin—lung cancer	6.08e-05	0.000252	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Docetaxel—lung cancer	6.07e-05	0.000252	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Methotrexate—lung cancer	6.06e-05	0.000251	CcSEcCtD
Gadobenate Dimeglumine—Flushing—Doxorubicin—lung cancer	6.05e-05	0.000251	CcSEcCtD
Gadobenate Dimeglumine—Cardiac disorder—Doxorubicin—lung cancer	6.05e-05	0.000251	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Paclitaxel—lung cancer	5.99e-05	0.000249	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Doxorubicin—lung cancer	5.92e-05	0.000245	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Methotrexate—lung cancer	5.91e-05	0.000245	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Etoposide—lung cancer	5.91e-05	0.000245	CcSEcCtD
Gadobenate Dimeglumine—Immune system disorder—Doxorubicin—lung cancer	5.89e-05	0.000244	CcSEcCtD
Gadobenate Dimeglumine—Mediastinal disorder—Doxorubicin—lung cancer	5.88e-05	0.000244	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Docetaxel—lung cancer	5.87e-05	0.000243	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Docetaxel—lung cancer	5.87e-05	0.000243	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Methotrexate—lung cancer	5.87e-05	0.000243	CcSEcCtD
Gadobenate Dimeglumine—Chills—Doxorubicin—lung cancer	5.85e-05	0.000243	CcSEcCtD
Gadobenate Dimeglumine—Arrhythmia—Doxorubicin—lung cancer	5.82e-05	0.000242	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Paclitaxel—lung cancer	5.79e-05	0.00024	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Cisplatin—lung cancer	5.79e-05	0.00024	CcSEcCtD
Gadobenate Dimeglumine—Cough—Methotrexate—lung cancer	5.72e-05	0.000237	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Doxorubicin—lung cancer	5.71e-05	0.000237	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Etoposide—lung cancer	5.68e-05	0.000236	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Doxorubicin—lung cancer	5.68e-05	0.000235	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Doxorubicin—lung cancer	5.68e-05	0.000235	CcSEcCtD
Gadobenate Dimeglumine—Rash—Etoposide—lung cancer	5.63e-05	0.000234	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Etoposide—lung cancer	5.63e-05	0.000233	CcSEcCtD
Gadobenate Dimeglumine—Headache—Etoposide—lung cancer	5.59e-05	0.000232	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Methotrexate—lung cancer	5.58e-05	0.000232	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Methotrexate—lung cancer	5.58e-05	0.000232	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Methotrexate—lung cancer	5.58e-05	0.000232	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Paclitaxel—lung cancer	5.57e-05	0.000231	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Doxorubicin—lung cancer	5.56e-05	0.000231	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	5.54e-05	0.00023	CcSEcCtD
Gadobenate Dimeglumine—Rash—Paclitaxel—lung cancer	5.52e-05	0.000229	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Paclitaxel—lung cancer	5.52e-05	0.000229	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Methotrexate—lung cancer	5.51e-05	0.000229	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Doxorubicin—lung cancer	5.49e-05	0.000228	CcSEcCtD
Gadobenate Dimeglumine—Headache—Paclitaxel—lung cancer	5.49e-05	0.000228	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Docetaxel—lung cancer	5.47e-05	0.000227	CcSEcCtD
Gadobenate Dimeglumine—Muscle spasms—Doxorubicin—lung cancer	5.46e-05	0.000226	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Methotrexate—lung cancer	5.39e-05	0.000224	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Methotrexate—lung cancer	5.35e-05	0.000222	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Docetaxel—lung cancer	5.32e-05	0.000221	CcSEcCtD
Gadobenate Dimeglumine—Infection—Methotrexate—lung cancer	5.31e-05	0.00022	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Etoposide—lung cancer	5.3e-05	0.00022	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Doxorubicin—lung cancer	5.27e-05	0.000218	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Docetaxel—lung cancer	5.25e-05	0.000218	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Methotrexate—lung cancer	5.25e-05	0.000218	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Doxorubicin—lung cancer	5.25e-05	0.000218	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Paclitaxel—lung cancer	5.2e-05	0.000216	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Methotrexate—lung cancer	5.2e-05	0.000216	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Methotrexate—lung cancer	5.17e-05	0.000215	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Doxorubicin—lung cancer	5.12e-05	0.000212	CcSEcCtD
Gadobenate Dimeglumine—Syncope—Doxorubicin—lung cancer	5.09e-05	0.000211	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Doxorubicin—lung cancer	5.08e-05	0.000211	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Docetaxel—lung cancer	5.08e-05	0.000211	CcSEcCtD
Gadobenate Dimeglumine—Palpitations—Doxorubicin—lung cancer	5.02e-05	0.000208	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Methotrexate—lung cancer	5e-05	0.000207	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Doxorubicin—lung cancer	4.99e-05	0.000207	CcSEcCtD
Gadobenate Dimeglumine—Cough—Doxorubicin—lung cancer	4.95e-05	0.000205	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Docetaxel—lung cancer	4.91e-05	0.000204	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Doxorubicin—lung cancer	4.9e-05	0.000203	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Methotrexate—lung cancer	4.87e-05	0.000202	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Doxorubicin—lung cancer	4.83e-05	0.0002	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Doxorubicin—lung cancer	4.83e-05	0.0002	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Doxorubicin—lung cancer	4.83e-05	0.0002	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Doxorubicin—lung cancer	4.82e-05	0.0002	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Methotrexate—lung cancer	4.8e-05	0.000199	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	4.8e-05	0.000199	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Doxorubicin—lung cancer	4.77e-05	0.000198	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Methotrexate—lung cancer	4.77e-05	0.000198	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Methotrexate—lung cancer	4.76e-05	0.000197	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Doxorubicin—lung cancer	4.73e-05	0.000196	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Docetaxel—lung cancer	4.72e-05	0.000196	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Methotrexate—lung cancer	4.71e-05	0.000195	CcSEcCtD
Gadobenate Dimeglumine—Rash—Docetaxel—lung cancer	4.68e-05	0.000194	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Docetaxel—lung cancer	4.68e-05	0.000194	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Doxorubicin—lung cancer	4.67e-05	0.000194	CcSEcCtD
Gadobenate Dimeglumine—Headache—Docetaxel—lung cancer	4.65e-05	0.000193	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Doxorubicin—lung cancer	4.63e-05	0.000192	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Methotrexate—lung cancer	4.62e-05	0.000192	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Methotrexate—lung cancer	4.61e-05	0.000191	CcSEcCtD
Gadobenate Dimeglumine—Infection—Doxorubicin—lung cancer	4.6e-05	0.000191	CcSEcCtD
Gadobenate Dimeglumine—Pain—Methotrexate—lung cancer	4.57e-05	0.00019	CcSEcCtD
Gadobenate Dimeglumine—Shock—Doxorubicin—lung cancer	4.56e-05	0.000189	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Doxorubicin—lung cancer	4.54e-05	0.000188	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Doxorubicin—lung cancer	4.52e-05	0.000188	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Doxorubicin—lung cancer	4.5e-05	0.000187	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Doxorubicin—lung cancer	4.48e-05	0.000186	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Docetaxel—lung cancer	4.41e-05	0.000183	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Methotrexate—lung cancer	4.41e-05	0.000183	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Methotrexate—lung cancer	4.37e-05	0.000181	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Doxorubicin—lung cancer	4.33e-05	0.00018	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Methotrexate—lung cancer	4.25e-05	0.000176	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Methotrexate—lung cancer	4.23e-05	0.000175	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Methotrexate—lung cancer	4.23e-05	0.000175	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Doxorubicin—lung cancer	4.22e-05	0.000175	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Doxorubicin—lung cancer	4.16e-05	0.000173	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Doxorubicin—lung cancer	4.13e-05	0.000171	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Doxorubicin—lung cancer	4.12e-05	0.000171	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Doxorubicin—lung cancer	4.08e-05	0.000169	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Doxorubicin—lung cancer	4e-05	0.000166	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Doxorubicin—lung cancer	3.99e-05	0.000166	CcSEcCtD
Gadobenate Dimeglumine—Pain—Doxorubicin—lung cancer	3.96e-05	0.000164	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Doxorubicin—lung cancer	3.96e-05	0.000164	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Methotrexate—lung cancer	3.94e-05	0.000164	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Methotrexate—lung cancer	3.84e-05	0.000159	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Doxorubicin—lung cancer	3.82e-05	0.000158	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Doxorubicin—lung cancer	3.79e-05	0.000157	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Methotrexate—lung cancer	3.78e-05	0.000157	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Doxorubicin—lung cancer	3.68e-05	0.000153	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Doxorubicin—lung cancer	3.66e-05	0.000152	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Doxorubicin—lung cancer	3.66e-05	0.000152	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Methotrexate—lung cancer	3.66e-05	0.000152	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Methotrexate—lung cancer	3.54e-05	0.000147	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Doxorubicin—lung cancer	3.41e-05	0.000142	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Methotrexate—lung cancer	3.4e-05	0.000141	CcSEcCtD
Gadobenate Dimeglumine—Rash—Methotrexate—lung cancer	3.37e-05	0.00014	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Methotrexate—lung cancer	3.37e-05	0.00014	CcSEcCtD
Gadobenate Dimeglumine—Headache—Methotrexate—lung cancer	3.35e-05	0.000139	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Doxorubicin—lung cancer	3.32e-05	0.000138	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Doxorubicin—lung cancer	3.28e-05	0.000136	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Methotrexate—lung cancer	3.18e-05	0.000132	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Doxorubicin—lung cancer	3.17e-05	0.000131	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Doxorubicin—lung cancer	3.06e-05	0.000127	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Doxorubicin—lung cancer	2.94e-05	0.000122	CcSEcCtD
Gadobenate Dimeglumine—Rash—Doxorubicin—lung cancer	2.92e-05	0.000121	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Doxorubicin—lung cancer	2.92e-05	0.000121	CcSEcCtD
Gadobenate Dimeglumine—Headache—Doxorubicin—lung cancer	2.9e-05	0.00012	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Doxorubicin—lung cancer	2.75e-05	0.000114	CcSEcCtD
